A study evaluating role of 68Ga-PSMA-PET imaging in staging and radiotherapy management in patients with biochemically recurrent prostate cancer.
Phase of Trial: Phase IV
Latest Information Update: 04 Sep 2017
At a glance
- Drugs Gallium 68 PSMA (Primary)
- Indications Prostate cancer
- Focus Diagnostic use
- 04 Sep 2017 New trial record